Clinical Trial Update: A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and efficacy of lebrikizumab in chronic obstructive pulmonary disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Lebrikizumab (lebrikizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Chronic Obstructive Pulmonary Disease | Phase 2 | Status: COMPLETED